Dieter Lindskog, MD, is an orthopaedic surgeon who specializes in bone and soft tissue sarcoma, a rare type of cancer found in the body’s connective tissue, and metastatic bone disease.
Dr. Lindskog, who is also section chief of musculoskeletal oncology, treats patients with both benign (noncancerous) and malignant (cancerous) tumors. His clinical practice is directed nearly full-time at the management of sarcomas and metastatic disease to bone, a rare specialty in the medical field.
Alongside his clinical practice, Dr. Lindskog is dedicated to improving surgical techniques and patient outcomes through research, studying the results of different reconstructive techniques following sarcoma resections and of minimally invasive techniques for treating benign bone lesions.
"Something drew me to the idea of saving someone’s life, in addition to improving their function and well-being. It’s different from the rest of orthopaedics. Not much else deals with life and death issues,” he says.
Dr. Lindskog’s commitment to oncology may have roots in his family history. He now walks the same halls as his grandfather, Gustaf Lindskog, MD, who was a leading thoracic surgeon at Yale and played a pivotal role in the development of the first chemotherapy treatment for cancer in the 1940s. "This is home. Joining the faculty at Yale was a wonderful opportunity. There’s that connection with him having been here,” he says.
Dr. Lindskog, an associate professor of orthopaedics and rehabilitation at Yale School of Medicine, received his medical degree from New York Medical College, completed a residency at Yale New Haven Hospital, and a fellowship at the University of Florida - Shands Teaching Hospital.
